TABLE 2.
Clinical information of the high CRG-Score and low CRG-Score groups.
| Covariates | High CRG-Score | Low CRG-Score | p value |
|---|---|---|---|
| Age | 0.2477 | ||
| age≤65 | 123 (41.14%) | 112 (46.47%) | |
| age>65 | 176 (58.86%) | 129 (53.53%) | |
| Gender | 0.5338 | ||
| Female | 136 (45.48%) | 117 (48.55%) | |
| Male | 163 (54.52%) | 124 (51.45%) | |
| Stage | 0.0389 | ||
| I | 45 (15.05%) | 48 (19.92%) | |
| II | 106 (35.45%) | 101 (41.91%) | |
| III | 91 (30.43%) | 57 (23.65%) | |
| IV | 50 (16.72%) | 27 (11.2%) | |
| unknown | 7 (2.34%) | 8 (3.32%) | |
| T stage | 0.0318 | ||
| T1 | 4 (1.34%) | 11 (4.56%) | |
| T2 | 48 (16.05%) | 45 (18.67%) | |
| T3 | 203 (67.89%) | 165 (68.46%) | |
| T4 | 43 (14.38%) | 20 (8.3%) | |
| Tis | 1 (0.33%) | 0 (0%) | |
| N stage | 0.0019 | ||
| N0 | 157 (52.51%) | 160 (66.39%) | |
| N1 | 78 (26.09%) | 51 (21.16%) | |
| N2 | 64 (21.4%) | 29 (12.03%) | |
| unknown | 0 (0%) | 1 (0.41%) | |
| M stage | 0.114 | ||
| M0 | 216 (72.24%) | 185 (76.76%) | |
| M1 | 49 (16.39%) | 27 (11.2%) | |
| unknown | 34 (11.37%) | 29 (12.03%) |